Happy to share our latest paper
rdcu.be/XsAVLKGTAora – at Eagan, MN
2
48
Zordoky_Lab retweeted
Talk about a true giant. Steve Lipshultz was a pioneer in the field of #CardioOnc & an outstanding mentor & friend. RIP. @ICOSociety @ESCardioOnco @DrJESalem
medicine.buffalo.edu/about/l…
Zordoky_Lab retweeted
A resident showed me an AI-generated assessment last week. It read beautifully and was wrong in a way only someone who already knew the medicine would catch. She caught it. That is the whole point.
Zordoky_Lab retweeted
This statement outlines a standardized framework for CV endpoints, including clear definitions, adjudication, baseline testing, surveillance, and the use of biomarkers and patient-reported outcomes.
Its broader aim is to make oncology trials more consistent, clinically relevant, and regulator-ready, while strengthening collaboration between oncology and cardiology to better assess net clinical benefit.
✍🏼 @AnaBaracCardio @avirupguha @MarcBonaca @anita_deswal @LalehAmiri @DrRaulCordoba @DrAlexAdjei
Zordoky_Lab retweeted
Thank you @BIDMC_CancerCtr for the opportunity to share our research with our growing cancer survivor population @BIDMChealth
Grateful for the support of @BidmcCvi @BIDMC_Research @DanaFarber @AmericanCancer as we build our basic and translational research program in #CardioOnc
💡Researchers at BIDMC are using a new technology that can detect 5,000 proteins in a small blood sample to study how anthracycline chemotherapy may affect heart function, and help inform safer care, for patients with #lymphoma.
@AartiAsnaniMD @BidmcCvi
Zordoky_Lab retweeted
In this #JACCCardioOnc review, the authors highlight the established cardioprotective benefits of #SGLT2i in #heartfailure and review emerging preclinical and clinical evidence supporting their potential role in #CardioOnc. jacc.org/doi/10.1016/j.jacca… @Zordoky_Lab @BlaesAnneMD
Zordoky_Lab retweeted
Merry Christmas and Happy Holidays from NIH! 🌟
Wishing you peace, joy, and good health this holiday season! 🌟🎄
From all of us at NIH, thank you for supporting science and discovery. 🔬 🧪
#MerryChristmas #HappyHolidays #NIH
I am pleased to share our latest paper. Differences between N and J really matter link.springer.com/10.1007/s1…
2
62
Zordoky_Lab retweeted
LHI Lecture Oct. 22, noon: Aarti Asnani, M.D. “Of Mice and Molecules: Uncovering Basic Mechanisms of Cardiotoxicity.” 1-101 Microbiology Research Facility | More info: z.umn.edu/LHIlecture | Webcast: z.umn.edu/lhi-webcast #UMNresearch #UMNheart
It's my honor to co-edit this collection at Cardiovascular Toxicology-looking forward to receiving your fantastic science
link.springer.com/collection…
3
60
NIH Publishes Plan to Drive Gold Standard Science | National Institutes of Health (NIH) share.google/UP0rN0sM2xWofO1…
1
100
Zordoky_Lab retweeted
🚨 We are delighted to welcome Dr. Beshay Zordoky to the Editorial Board of the Journal of Cardiovascular Aging! 🎉
Welcome aboard, Dr. Zordoky! 💼🫀
#Cardiotoxicity #CancerSurvivorship #AgingResearch
Zordoky_Lab retweeted
.@NIHDirector_Jay and Dr. @NKleinstreuer talk about NIH’s shift toward human-focused research and how NIH will no longer issue NOFOs exclusively for animal models.
Watch the latest episode of The Director’s Desk to hear more: youtube.com/watch?v=iSvk6iMx…
Zordoky_Lab retweeted
Cardiovascular toxicity of breast cancer treatments: from understandin... sciencedirect.com/science/ar…
Exciting year at ASCO 2025 with new treatment options for those living with advanced breast cancer - let’s not forget about the impact on cardiovascular health. @ASCO @ICOSociety
Zordoky_Lab retweeted
Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients
onlinelibrary.wiley.com/doi/…
Zordoky_Lab retweeted
Very glad to see our recent work in press at @CircAHA . Alternatively activated macrophages driven by IL-4 signaling sustain a parainflammatory response in the failing heart. Kudos to @QiongxinWang for her tireless work on this study
CD206⁺IL-4Rα⁺ macrophages proliferate and drive adverse LV remodeling via FIZZ1-mediated fibrosis. IL-4Rα deletion or silencing reverses remodeling and improves function. A novel therapeutic target in ischemic cardiomyopathy ahajournals.org/doi/full/10.…
Take a look at our latest article! It's the first fruit of my collaboration with @CamellChristina. Stay tuned, many more to come
nature.com/articles/s41598-0…
Minnesota, Hats Off To Thee @UMNCancer Research Symposium




















